New ALS drug shows promise in Mid-Stage trial
NCT ID NCT05357950
Summary
This study tested whether a drug called PrimeC is safe and can help slow down ALS. For six months, 69 people with ALS took either PrimeC or a placebo pill twice daily, while continuing their standard ALS medications. Researchers checked for side effects and measured changes in physical function, breathing, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O.U. Citta della Salute e della Scienza di Torino
Torino, Italy
-
IRCCS Istituti clinici Maugeri
Milan, Italy
-
Lawson Health Research Institute
London, Ontario, Canada
-
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Conditions
Explore the condition pages connected to this study.